Correlation Between JB Chemicals and Krebs Biochemicals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both JB Chemicals and Krebs Biochemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JB Chemicals and Krebs Biochemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between JB Chemicals Pharmaceuticals and Krebs Biochemicals and, you can compare the effects of market volatilities on JB Chemicals and Krebs Biochemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JB Chemicals with a short position of Krebs Biochemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of JB Chemicals and Krebs Biochemicals.

Diversification Opportunities for JB Chemicals and Krebs Biochemicals

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between JBCHEPHARM and Krebs is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding JB Chemicals Pharmaceuticals and Krebs Biochemicals and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krebs Biochemicals and and JB Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JB Chemicals Pharmaceuticals are associated (or correlated) with Krebs Biochemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krebs Biochemicals and has no effect on the direction of JB Chemicals i.e., JB Chemicals and Krebs Biochemicals go up and down completely randomly.

Pair Corralation between JB Chemicals and Krebs Biochemicals

Assuming the 90 days trading horizon JB Chemicals is expected to generate 11.97 times less return on investment than Krebs Biochemicals. But when comparing it to its historical volatility, JB Chemicals Pharmaceuticals is 4.16 times less risky than Krebs Biochemicals. It trades about 0.07 of its potential returns per unit of risk. Krebs Biochemicals and is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  8,697  in Krebs Biochemicals and on September 13, 2024 and sell it today you would earn a total of  2,423  from holding Krebs Biochemicals and or generate 27.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

JB Chemicals Pharmaceuticals  vs.  Krebs Biochemicals and

 Performance 
       Timeline  
JB Chemicals Pharmac 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days JB Chemicals Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, JB Chemicals is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.
Krebs Biochemicals and 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

JB Chemicals and Krebs Biochemicals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with JB Chemicals and Krebs Biochemicals

The main advantage of trading using opposite JB Chemicals and Krebs Biochemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JB Chemicals position performs unexpectedly, Krebs Biochemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krebs Biochemicals will offset losses from the drop in Krebs Biochemicals' long position.
The idea behind JB Chemicals Pharmaceuticals and Krebs Biochemicals and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance